Literature DB >> 24273688

Increased Nitric Oxide Production Prevents Airway Hyperresponsiveness in Caveolin-1 Deficient Mice Following Endotoxin Exposure.

Bethany J Hsia1, Amy M Pastva, Charles D Giamberardino, Erin N Potts-Kant, W Michael Foster, Loretta G Que, Soman N Abraham, Jo Rae Wright, David W Zaas.   

Abstract

BACKGROUND: Caveolin-1, the hallmark protein of caveolae, is highly expressed within the lung in the epithelium, endothelium, and in immune cells. In addition to its classical roles in cholesterol metabolism and endocytosis, caveolin-1 has also been shown to be important in inflammatory signaling pathways. In particular, caveolin-1 is known to associate with the nitric oxide synthase enzymes, downregulating their activity. Endotoxins, which are are composed mainly of lipopolysaccharide (LPS), are found ubiquitously in the environment and can lead to the development of airway inflammation and increased airway hyperresponsiveness (AHR).
METHODS: We compared the acute responses of wild-type and caveolin-1 deficient mice after LPS aerosol, a well-accepted mode of endotoxin exposure, to investigate the role of caveolin-1 in the development of environmental lung injury.
RESULTS: Although the caveolin-1 deficient mice had greater lung inflammatory indices compared to wild-type mice, they exhibited reduced AHR following LPS exposure. The uncoupling of inflammation and AHR led us to investigate the role of caveolin-1 in the production of nitric oxide, which is known to act as a bronchodilator. The absence of caveolin-1 resulted in increased nitrite levels in the lavage fluid in both sham and LPS treated mice. Additionally, inducible nitric oxide synthase expression was increased in the lung tissue of caveolin-1 deficient mice following LPS exposure and administration of the potent and specific inhibitor 1400W increased AHR to levels comparable to wild-type mice.
CONCLUSIONS: We attribute the relative airway hyporesponsiveness in the caveolin-1 deficient mice after LPS exposure to the specific role of caveolin-1 in mediating nitric oxide production.

Entities:  

Keywords:  Airway hyperresponsiveness; Caveolin-1; Cytokines; Lipopolysaccharide; Lung injury; Nitric oxide

Year:  2012        PMID: 24273688      PMCID: PMC3836011          DOI: 10.4172/2155-6121.S1-004

Source DB:  PubMed          Journal:  J Allergy Ther


  45 in total

1.  Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function.

Authors:  G R Newman; L Campbell; C von Ruhland; B Jasani; M Gumbleton
Journal:  Cell Tissue Res       Date:  1999-01       Impact factor: 5.249

2.  Local inflammatory responses following bronchial endotoxin instillation in humans.

Authors:  N P O'Grady; H L Preas; J Pugin; C Fiuza; M Tropea; D Reda; S M Banks; A F Suffredini
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

3.  Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry.

Authors:  R Djukanović; J W Wilson; K M Britten; S J Wilson; A F Walls; W R Roche; P H Howarth; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1990-10

4.  Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Authors:  S A Bryan; B J O'Connor; S Matti; M J Leckie; V Kanabar; J Khan; S J Warrington; L Renzetti; A Rames; J A Bock; M J Boyce; T T Hansel; S T Holgate; P J Barnes
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

5.  Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide.

Authors:  Sean Garrean; Xiao-Pei Gao; Victor Brovkovych; Jun Shimizu; You-Yang Zhao; Stephen M Vogel; Asrar B Malik
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

6.  Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury.

Authors:  Guochang Hu; Richard D Ye; Mary C Dinauer; Asrar B Malik; Richard D Minshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

7.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.

Authors:  You-Yang Zhao; Yang Liu; Radu-Virgil Stan; Lian Fan; Yusu Gu; Nancy Dalton; Po-Hsien Chu; Kirk Peterson; John Ross; Kenneth R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

8.  Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung.

Authors:  G Bannenberg; J Xue; L Engman; I Cotgreave; P Moldéus; A Ryrfeldt
Journal:  J Pharmacol Exp Ther       Date:  1995-03       Impact factor: 4.030

9.  Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects.

Authors:  P J Jagielo; P S Thorne; J L Watt; K L Frees; T J Quinn; D A Schwartz
Journal:  Chest       Date:  1996-07       Impact factor: 9.410

Review 10.  Reactive nitrogen species in the respiratory tract.

Authors:  Fabio L M Ricciardolo; Antonino Di Stefano; Federica Sabatini; Gert Folkerts
Journal:  Eur J Pharmacol       Date:  2006-02-07       Impact factor: 4.432

View more
  2 in total

1.  Antigen-induced airway hyperresponsiveness and obstruction is related to caveolin-1 expression in airway smooth muscle in a guinea pig asthma model.

Authors:  Mayra Álvarez-Santos; Patricia Ramos-Ramírez; Fernando Gutiérrez-Aguilar; Sandra Sánchez-Hernández; Ricardo Lascurain; Raúl Olmos-Zuñiga; Rogelio Jasso-Victoria; Norma A Bobadilla; Blanca Bazan-Perkins
Journal:  Clin Transl Allergy       Date:  2015-03-26       Impact factor: 5.871

2.  Relationship between Particulate Matter (PM10) and Airway Inflammation Measured with Exhaled Nitric Oxide Test in Seoul, Korea.

Authors:  Juwhan Choi; Jae Kyeom Sim; Jee Youn Oh; Young Seok Lee; Gyu Young Hur; Sung Yong Lee; Jae Jeong Shim; Ji-Yong Moon; Kyung Hoon Min
Journal:  Can Respir J       Date:  2020-03-17       Impact factor: 2.409

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.